KBIO Stock Price Today

( )
KBIO PreMarket: $ () as of AM

KBIO Stock Quote

Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.

Company Profile

Humanigen, Inc. engages in the development of monoclonal antibodies for various oncology indications and to enhance T-cell therapies. Its lead product candidate is lenzilumab, is a novel humaneered monoclonal antibody. The company was founded on March 15, 2000 and is headquartered in Burlingame, CA.